Mariusz Stasiolek
Overview
Explore the profile of Mariusz Stasiolek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajewski B, Karlinska I, Domowicz M, Bednarski I, Swiderek-Matysiak M, Stasiolek M
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858462
Despite significant efforts, there is still an existing need to identify diagnostic tools that would enable fast and reliable detection of the progressive stage of multiple sclerosis (MS) and help...
2.
Rosciszewska-Zukowska I, Kulakowska A, Kalinowska A, Bartosik-Psujek H, Mirowska-Guzel D, Stasiolek M, et al.
Neurol Neurochir Pol
. 2025 Jan;
59(1):20-32.
PMID: 39811975
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) that is usually diagnosed between the ages of 20 and 40. Changes in the immune system...
3.
Mirowska-Guzel D, Nojszewska M, Jaroszewicz J, Kalinowska A, Kulakowska A, Ledwoch J, et al.
Neurol Neurochir Pol
. 2025 Jan;
59(1):1-5.
PMID: 39807949
A working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society, the Polish Society of Family Medicine, and the Polish Society of Vaccinology has...
4.
Jatczak-Pawlik I, Jurewicz A, Domowicz M, Ewiak-Paszynska A, Stasiolek M
Cells
. 2025 Jan;
13(24.
PMID: 39768177
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) with a complex and not fully understood etiopathological background involving inflammatory and neurodegenerative processes. CHI3L1 has...
5.
Kulakowska A, Mirowska-Guzel D, Kalinowska A, Bartosik-Psujek H, Brola W, Stasiolek M, et al.
Neurol Neurochir Pol
. 2024 Dec;
58(6):569-585.
PMID: 39737584
The treatment of multiple sclerosis (MS) has undergone significant changes since the first disease-modifying therapy (DMT) drug was introduced. Currently, 19 original DMT drugs are registered in the European Union....
6.
Zakrzewska-Pniewska B, Bartosik-Psujek H, Brola W, Golebiowski M, Kalinowska A, Kulakowska A, et al.
Neurol Neurochir Pol
. 2024 Dec;
59(1):6-19.
PMID: 39692818
Introduction: An expert panel of the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society has developed principles for the management of neuromyelitis optica spectrum disorders (NMOSD). These...
7.
Niedziela N, Nowak-Kiczmer M, Malciene L, Stasiolek M, Niedziela J, Czuba Z, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408830
Permanent inflammatory demyelinating and neurodegenerative processes lead to neurological disability in patients with multiple sclerosis (MS). The anti-inflammatory properties of vitamin D (VitD) are well established, but its role in...
8.
Niedziela N, Nowak-Kiczmer M, Malciene L, Stasiolek M, Zalejska-Fiolka J, Czuba Z, et al.
Diagnostics (Basel)
. 2024 Sep;
14(17).
PMID: 39272777
Background: Inflammatory demyelination and impaired recovery processes result in permanent neurodegeneration and neurological disability in patients with multiple sclerosis (MS). In terms of smoldering MS, chronic neuroinflammation develops in the...
9.
Fernandes E, Wildner P, Oset M, Siger M, Stasiolek M, Matysiak M, et al.
Int Ophthalmol
. 2024 Jun;
44(1):281.
PMID: 38922460
Purpose: The aim of this study is to analyse whether optical coherence tomography angiography (angio-OCT, OCTA) measurements can be a useful tool to differentiate central nervous system (CNS) involvement in...
10.
Niedziela N, Kalinowska A, Kulakowska A, Mirowska-Guzel D, Rejdak K, Siger M, et al.
Neurol Neurochir Pol
. 2024 Jun;
58(3):245-255.
PMID: 38842128
Introduction: Assessment of the clinical course, neuroimaging and histopathological changes suggests that multiple sclerosis (MS) should not be defined merely as a focal inflammatory disease of the central nervous system...